Verisante gets $1.1M boost for skin cancer detection device

11/15/2013 | (Boston)

A prospectus offering has brought in $1.1 million for Verisante Technology. The Canadian firm will use part of the proceeds to support its efforts to market, further develop, manufacture and obtain U.S. regulatory approval for its Aura system, which is used to detect skin cancer.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC